Tag: NASDAQ:CORV

December 24, 2019

Correvio Fails to Get FDA Approval for Anti-arrhythmic Drug

Correvio Pharma announced that the FDA would not be approving its anti-arrhythmic drug in its current form.
April 30, 2019

BBHIC 2019, Day 1: Notes from the Floor

For INN, day one was full of company presentations, interviews and a panel discussion on commercial-stage healthcare companies.
January 27, 2019

5 Top Weekly NASDAQ Biotech Stocks: Synergy on Top

Synergy Pharmaceuticals, Alpine Immune Sciences, Aerpio Pharmaceuticals, Correvio Pharma and Athersys were last week's top gainers.
December 20, 2018

5 Top Biotech and Pharma Stocks on the TSX Year-to-Date

Which biotech and pharma stocks on the TSX have performed the best in 2018? Here's a look at the top...
December 3, 2018

5 Top NASDAQ Pharma Stocks Year-to-Date

With Q4 and 2018 almost over, the Investing News Network is taking a look back at the five top NASDAQ...
November 4, 2018

5 Top Weekly NASDAQ Biotech Stocks: Aptose Leads this Week

Aptose Biosciences, Trevena, Curis, Geron and Aveo Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
October 9, 2018

5 Top NASDAQ Pharma Stocks Q3 2018

With Q3 over and Q4 officially in the works, the Investing News Network is taking a look back at the...